Clinicopathologic Features Predicting Involvement of Nonsentinel Axillary Lymph Nodes in Iranian Women with Breast Cancer |
Moosavi, Seyed Alireza
(Department of Surgery, Tehran University of Medical Sciences)
Abdirad, Afshin (Department of Pathology, Tehran University of Medical Sciences) Omranipour, Ramesh (Department of Surgery, Tehran University of Medical Sciences) Hadji, Maryam (Cancer Research Center, Tehran University of Medical Sciences) Razavi, Amirnader Emami (Iran National Tumor Bank, Tehran University of Medical Sciences) Najafi, Massoome (Department of Surgery, Tehran University of Medical Sciences) |
1 | Van Calster B, Bempt IV, Drijkoningen M, et al (2009). Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat, 113, 181-7. DOI |
2 | Van la Parra R, Peer P, Ernst M, et al (2011). Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol, 37, 290-9. DOI |
3 | Van Zee KJ, Manasseh D-ME, Bevilacqua JL, et al (2003). A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol, 10, 1140-51. DOI ScienceOn |
4 | Viale G, Maiorano E, Pruneri G, et al (2005). Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg, 241, 319-25. DOI ScienceOn |
5 | Wada N, Imoto S, Yamauchi C, et al (2006). Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol, 32, 29-33. DOI |
6 | Yu J, Hsu GC, Hsieh CB, et al (2005). Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg, 29, 813-8. DOI ScienceOn |
7 | Altinyollar H, Berberoglu U, Gulben K, et al (2007). The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer. J Surg Oncol, 95, 567-71. DOI ScienceOn |
8 | Alvarenga CA, Santos CCd, Alvarenga M, et al (2013). Localization of metastasis within the sentinel lymph node biopsies: a predictor of additional axillary spread of breast cancer? Rev Bras Ginecol Obstet, 35, 483-99. DOI |
9 | Ashikaga T, Krag DN, Land SR, et al (2010). Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol, 102, 111-8. DOI |
10 | Baker TA, Wadhwani N, Rajan P, et al (2012). The size of metastasis in the sentinel node is a predictor of additional non-sentinel node positivity. J Cancer Ther, 3, 712-7. DOI |
11 | Barranger E, Coutant C, Flahault A, et al (2005). An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat, 91, 113-9. DOI ScienceOn |
12 | Beriwal S, Soran A, Kocer B, et al (2008). Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Am J Clin Oncol, 31, 34-8. DOI |
13 | Bevilacqua JLB, Kattan MW, Fey JV, et al (2007). Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol, 25, 3670-9. DOI ScienceOn |
14 | Boler D, Uras C, Ince U, et al (2012). Factors predicting the nonsentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases. The Breast, 21, 518-23. DOI |
15 | Bolster MJ, Peer PG, Bult P, et al (2007). Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol, 14, 181-9. DOI |
16 | Cady B (2001). Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients. J Surg Oncol, 77, 149-52. DOI |
17 | Chu KU, Turner RR, Hansen NM, et al (1999). Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg, 229, 536-41. DOI ScienceOn |
18 | Degnim AC, Griffith KA, Sabel MS, et al (2003). Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer, 98, 2307-15. DOI ScienceOn |
19 | Dubsky PC, Gnant MF, Taucher S, et al (2002). Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer, 3, 65-72. DOI |
20 | Eldweny H, Alkhaldy K, Alsaleh N, et al (2012). Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study). J Egypt Natl Canc Inst, 24, 23-30. DOI ScienceOn |
21 | Kohrt HE, Olshen RA, Bermas HR, et al (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer, 8, 66. DOI |
22 | Kwon Y, Ro J, Kang H-S, et al (2011). Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Oncol Rep, 25, 1063-71. |
23 | Lucci A, McCall LM, Beitsch PD, et al (2007). Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the american college of surgeons oncology group trial Z0011. J Clin Oncol, 25, 3657-63. DOI ScienceOn |
24 | McMasters KM, Tuttle TM, Carlson DJ, et al (2000). Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol, 18, 2560-6. |
25 | Mittendorf EA, Hunt KK, Boughey JC, et al (2012). Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg, 255, 109-15. DOI |
26 | Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. DOI ScienceOn |
27 | Noguchi M (2008). Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. Eur J Surg Oncol, 34, 129-34. DOI ScienceOn |
28 | Ozmen V, Karanlik H, Cabioglu N, et al (2006). Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat, 95, 1-6. DOI |
29 | Pal A, Provenzano E, Duffy S, et al (2008). A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg, 95, 302-9. DOI ScienceOn |
30 | Fant JS, Grant MD, Knox SM, et al (2003). Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol, 10, 126-30. DOI |
31 | Farshid G, Pradhan M, Kollias J, et al (2004). A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. The Breast, 13, 494-501. DOI ScienceOn |
32 | Friedman D, Gipponi M, Murelli F, et al (2013). Predictive factors of non-sentinel lymph node involvement in patients with invasive breast cancer and sentinel node micrometastases. Anticancer Res, 33, 4509-14. |
33 | Fujii T, Yanagita Y, Fujisawa T, et al (2010). Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: prediction of nonsentinel lymph node metastasis. World J Surg, 34, 544-8. DOI |
34 | Giuliano AE, Hunt KK, Ballman KV, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA, 305, 569-75. DOI ScienceOn |
35 | Goyal A, Douglas-Jones A, Newcombe R, et al (2004). Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer, 40, 1731-7. DOI ScienceOn |
36 | Guenther JM, Hansen NM, DiFronzo LA, et al (2003). Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg, 138, 52-6. DOI ScienceOn |
37 | Gur A, Unal B, Ozbek U, et al (2010). Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol, 36, 30-5. DOI ScienceOn |
38 | Guray Durak M, Akansu B, Akin MM, et al (2011). Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma. Turk Patoloji Derg, 27, 189-95. |
39 | Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7. |
40 | Jeruss JS, Winchester DJ, Sener SF, et al (2005). Axillary recurrence after sentinel node biopsy. Ann Surg Oncol, 12, 34-40. DOI ScienceOn |
41 | Jinno H, Sakata M, Asaga S, et al (2008). Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Breast J, 14, 551-5. DOI |
42 | Kapur U, Rubinas T, Ghai R, et al (2007). Prediction of nonsentinel lymph node metastasis in sentinel node-positive breast carcinoma. Ann Diagn Pathol, 11, 10-2. DOI |
43 | Koca B, Kuru B, Ozen N, et al (2014). A breast cancer nomogram for prediction of non-sentinel node metastasis-validation of fourteen existing models. Asian Pac J Cancer Prev, 15, 1481-8. 과학기술학회마을 DOI |
44 | Abdessalam SF, Zervos EE, Prasad M, et al (2001). Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg, 182, 316-20. DOI ScienceOn |
45 | Afsharfard A, Mozaffar M, Orang E, et al (2013). Trends in Epidemiology, Clinical and Histopathological Characteristics of Breast Cancer in Iran: Results of a 17 Year Study. Asian Pac J Cancer Prev, 14, 6905-11. 과학기술학회마을 DOI ScienceOn |
46 | Aitken E, Osman M (2010). Factors affecting nodal status in invasive breast cancer: a retrospective analysis of 623 patients. Breast J, 16, 271-8. DOI |
47 | Rahusen FD, Torrenga H, van Diest PJ, et al (2001). Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg, 136, 1059-63. DOI ScienceOn |
48 | Schrenk P, Rieger R, Shamiyeh A, et al (2000). Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer, 88, 608-14. DOI |
49 | Scomersi S, Torelli L, Zanconati F, et al (2012). Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy. Ann Ital Chir, 83, 461-8. |
50 | Silverstein MJ, Skinner KA, Lomis TJ (2001). Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg, 25, 767-72. DOI ScienceOn |
51 | Singletary SE, Allred C, Ashley P, et al (2002). Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol, 20, 3628-36. DOI ScienceOn |
52 | Singletary SE, Greene FL (2003). Revision of breast cancer staging: the 6th edition of the TNM Classification. Semin Surg Oncol, 21, 53-9 DOI ScienceOn |
53 | Stitzenberg KB, Meyer AA, Stern SL, et al (2003). Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg, 237, 607-12. |
54 | Turner RR, Chu KU, Qi K, et al (2000). Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer, 89, 574-81. DOI |
55 | Derici S, Sevinc A, Harmancioglu O, et al (2012). Validation of three breast cancer nomograms and a new formula for predicting non-sentinel lymph node status. Asian Pac J Cancer Prev, 13, 6181-5. 과학기술학회마을 DOI |
56 | Fougo JL, Afonso M, Senra FS, et al (2009). Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors? Clin Transl Oncol, 11, 165-71. DOI |
57 | Van Deurzen C, Van Hillegersberg R, Hobbelink M, et al (2007). Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol, 29, 497-505. |